Your search returned 2793 results.

Results
	41.	Gilteritinib is a clinically active FLT3 inhibitor with broad activity against FLT3 kinase domain mutations. [electronic resource] by Tarver, Theodore C Hill, Jason E Rahmat, Leena Perl, Alexander E Bahceci, Erkut Mori, Kenichi Smith, Catherine C Producer: 20210514 In: Blood advances vol. 4 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)
	42.	FLT3 and acute myelogenous leukemia: biology, clinical significance and therapeutic applications. [electronic resource] by Advani, Anjali S Producer: 20051220 In: Current pharmaceutical design vol. 11 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)
	43.	[Nucleophosmin mutations in hematological malignancies - review]. [electronic resource] by Luo, Zhan-Peng Zhang, Ling Producer: 20091211 In: Zhongguo shi yan xue ye xue za zhi vol. 15 Availability: No items available. Save to lists Add to cart (remove)
	44.	Presence of high-ERG expression is an independent unfavorable prognostic marker in MLL-rearranged childhood myeloid leukemia. [electronic resource] by Pigazzi, Martina Masetti, Riccardo Martinolli, Francesco Manara, Elena Beghin, Alessandra Rondelli, Roberto Locatelli, Franco Fagioli, Franca Pession, Andrea Basso, Giuseppe Producer: 20120313 In: Blood vol. 119 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)
	45.	[Study on relationship between Set gene expression and clinical manifestations in bone marrow of patients with acute myelogenous leukemia]. [electronic resource] by Liu, Y Lei, T Shi, Y Wang, X Y Sun, M L Fan, W X Zhang, Z N Jiang, M Producer: 20190128 In: Zhonghua yi xue za zhi vol. 98 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)
	46.	[NPM1 High Mutant Allele Burden is an Adverse Prognostic Factor for AML Patients with Mutated NPM1]. [electronic resource] by Hou, Jiang-Xue Wang, Shu-Juan Liu, Yan-Fang Hao, Qian-Qian Wang, Chong Li, Tao Bai, Jun-Jun Liao, Lin-Xiao Guo, Cheng-Yu Chang, Yin-Yin Wang, Meng Sun, Hui Xie, Xin-Sheng Jiang, Zhong-Xing Producer: 20190430 In: Zhongguo shi yan xue ye xue za zhi vol. 27 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)
	47.	[Detection of Genetic Mutations in Primary Hypereosinophilia Patients]. [electronic resource] by Zhou, Jie Wu, Hao Li, Bing Liang, Ai-Bin Fu, Jian-Fei Producer: 20190430 In: Zhongguo shi yan xue ye xue za zhi vol. 27 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)
	48.	CD30 in myeloid malignancies: hitting the bull's-eye with an available dart. [electronic resource] by Emadi, Ashkan Karp, Judith E Producer: 20130822 In: Leukemia & lymphoma vol. 54 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)
	49.	[The clinical and prognostic significance of acute myeloid leukemia with FLT3-ITD]. [electronic resource] by Lin, D Wei, H Wang, Y Zhou, C L Liu, B C Liu, K Q Gong, B F Wei, S N Zhang, G J Liu, Y T Gong, X Y Qiu, S W Mi, Y C Wang, J X Producer: 20181217 In: Zhonghua xue ye xue za zhi = Zhonghua xueyexue zazhi vol. 37 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)
	50.	Allogeneic transplant for FLT3-ITD+ AML: room for improvement. [electronic resource] by Perl, A E Luger, S M Producer: 20160824 In: Bone marrow transplantation vol. 51 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)
	51.	High dose daunorubicin: New standard of care for FLT3 ITD mutant AML. [electronic resource] by Wang, Eunice S O'Dwyer, Kristen Producer: 20190311 In: Leukemia research vol. 69 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)
	52.	[Analysis of Clinical and Laboratory Features of Patients with Acute Myeloid Leukemia(AML)-M1/M2 with Cuplike Nuclei Morphology]. [electronic resource] by Wang, Yan Qiao, Chun Guo, Rui Wang, Hui Yang, Hui Qiu, Hai-Rong Wu, Yu-Jie Zhang, Jian-Fu Wang, Rong Qian, Si-Xuan Li, Jian-Yong Producer: 20181113 In: Zhongguo shi yan xue ye xue za zhi vol. 26 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)
	53.	FLT3 mutations in patients with childhood acute lymphoblastic leukemia (ALL). [electronic resource] by Kabir, Nuzhat N Rönnstrand, Lars Kazi, Julhash U Producer: 20130725 In: Medical oncology (Northwood, London, England) vol. 30 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)
	54.	Allelic ratio: a marker of clonal dominance. [electronic resource] by Meshinchi, Soheil Producer: 20150223 In: Blood vol. 124 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)
	55.	The effect of FLT3-ITD and NPM1 mutation on survival in intensively treated elderly patients with cytogenetically normal acute myeloid leukemia. [electronic resource] by Rashidi, Armin Wolach, Ofir El-Jawahri, Areej Ho, Vincent T DiPersio, John F Soiffer, Robert Stone, Richard M Chen, Yi-Bin Producer: 20171109 In: Leukemia & lymphoma vol. 57 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)
	56.	The effect of FLT3-ITD and NPM1 mutation on survival in intensively treated elderly patients with cytogenetically normal acute myeloid leukemia - Response to Rashidi et al. [electronic resource] by McGregor, Andrew Kenneth Moulton, Deborah Bown, Nick Cuthbert, Gavin Bourn, David Mathew, Susanna Dang, Raymond Mounter, Phillip Jones, Gail Producer: 20171109 In: Leukemia & lymphoma vol. 57 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)
	57.	FLT3 overexpression in acute leukaemias: New insights into the search for molecular mechanisms. [electronic resource] by Poubel, Caroline Pires Mansur, Marcela B Boroni, Mariana Emerenciano, Mariana Producer: 20190919 In: Biochimica et biophysica acta. Reviews on cancer vol. 1872 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)
	58.	Molecular involvement and prognostic importance of fms-like tyrosine kinase 3 in acute myeloid leukemia. [electronic resource] by Shahab, Sadaf Shamsi, Tahirs Ahmed, Nuzhat Producer: 20130610 In: Asian Pacific journal of cancer prevention : APJCP vol. 13 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)
	59.	Prognostic Models Turn the Heat(IT)up on [electronic resource] by Gallipoli, Paolo Huntly, Brian J P Producer: 20191022 In: Clinical cancer research : an official journal of the American Association for Cancer Research vol. 25 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)
	60.	Polyclonal Heterogeneity: The New Norm for Secondary Clinical Resistance to Targeted Monotherapy in Relapsed Leukemia? [electronic resource] by Wei, Andrew H Roberts, Andrew W Producer: 20190826 In: Cancer discovery vol. 9 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)

First
Previous
1
2
3
4
5
6
7
8
9
10
Next
Last

Refine your search

Availability

Authors

Topics

Languages

Your search returned 2793 results.